Targeting nNOS suppresses AKT–TSC–mTOR signaling and inhibits neuroblastoma growth
Brain Medicine · 07.04.2026 · 2 (2) · 60-70
DOI: 10.61373/bm026a.0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Medicine, erschienen am 07.04.2026. Verfasst von Shashank Kumar Ojha und 5 weiteren Autor:innen. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroblastoma (NB) is the most common extracranial solid tumor in children, yet its molecular mechanisms remain elusive. In this mechanistic study, we investigated a novel cross-talk between nitric oxide (NO) and mTOR signaling in human SH-SY5Y neuroblastoma cells. We assessed whether pharmacological inhibition of neuronal NO synthase (nNOS) could attenuate NB malignancy by modulating mTOR signaling. Pharmacological inhibition of nNOS with BA-101 (100 μM, 24 h) or genetic silencing of nNOS with siRNA caused upregulation of the key negative regulator TSC2 and decreased phosphorylation of AKT, mTOR, and RPS6, indicating suppression of mTOR pathway activity. Conversely, exposure to the NO donor SNAP significantly elevated 3-nitrotyrosine levels (a marker of nitrosative stress) and enhanced activation of mTOR signaling components, suggesting that NO promotes oncogenic signaling in neuroblastoma cells. Importantly, pharmacological nNOS inhibition with BA-101 markedly suppressed xenograft tumor volume and weight in NOD-SCID mice (p < 0.001 vs. vehicle controls, n = 6 per group), demonstrating a critical role for nNOS-derived NO in neuroblastoma progression in vivo . In conclusion, nNOS-derived NO promotes neuroblastoma malignancy through activation of the mTOR pathway. Inhibition of nNOS suppresses mTOR signaling, reduces cellular malignancy, and attenuates tumor growth in vivo , identifying the nNOS-mTOR axis as a promising therapeutic target in neuroblastoma.
Zitieren
APA
Ojha, S. K., Tripathi, M. K., Khaliulin, I., Choudhary, V., Kartawy, M., & Amal, H. (2026). Targeting nNOS suppresses AKT–TSC–mTOR signaling and inhibits neuroblastoma growth. Brain Medicine, 2(2), 60-70. https://doi.org/10.61373/bm026a.0027
Vancouver
Ojha SK, Tripathi MK, Khaliulin I, Choudhary V, Kartawy M, Amal H. Targeting nNOS suppresses AKT–TSC–mTOR signaling and inhibits neuroblastoma growth. Brain Medicine. 2026;2(2):60-70. doi:10.61373/bm026a.0027
BibTeX
@article{Ojha2026,
author = {Ojha, Shashank Kumar and Tripathi, Manish Kumar and Khaliulin, Igor and Choudhary, Vikas and Kartawy, Maryam and Amal, Haitham},
title = {Targeting nNOS suppresses AKT–TSC–mTOR signaling and inhibits neuroblastoma growth},
journal = {Brain Medicine},
year = {2026},
volume = {2},
number = {2},
pages = {60--70},
doi = {10.61373/bm026a.0027}
}
EUVIMED